Infectious Diseases Segment Bolsters Veterinary Diagnostics Products Market Growth

According to our new research study on "Veterinary Diagnostics Products Market Forecast to 2031 - Global Analysis - by Product, Animal Type, Application, and End User", the market was valued at US$8.68 billion in 2024 and is projected to reach US$16.68 billion by 2031; it is estimated to register a CAGR of 9.9% during 2025-2031. The veterinary diagnostics products market report emphasizes the trends prevalent in the global market and drivers and deterrents affecting its growth.

The surging prevalence of zoonotic diseases, soaring initiatives for animal health, growing pet ownership, and companion animal adoption contribute to the ever-increasing veterinary diagnostics products market size. However, the high cost of veterinary diagnostic kits and associated equipment hamper the growth of the market. Further, advancements in portable molecular diagnostic kits will bring new veterinary diagnostics products market trends in the coming years.

Growing Pet Ownership and Companion Animal Adoption Bolster Veterinary Diagnostics Products Market Growth

According to a report by HealthforAnimals published in 2024, the global pet population exceeded to 1 billion animals, with over 470 million dogs and 370 million cats worldwide as of 2018, and continued growth observed through 2024. This surge is driven by urbanization, evolving lifestyles, and heightened emotional bonds with companion animals, especially dogs and cats, as highlighted in global sector analyses. Urban dwellers, now comprising over half the world's population, increasingly seek pets for companionship in fast-paced city environments, leading to preferences for smaller breeds suited to compact living spaces. This growing pet population fuels demand for diagnostic kits for diseases such as canine parvovirus and feline leukemia, as owners prioritize preventive healthcare.

The State of Pet Homelessness Index by Mars Petcare (2024) estimates that 1 in 3 companion animals globally, over 600 million dogs and cats, are homeless or at risk, underscoring the urgent need for adoption programs.

Companion animal adoption trends are steadily increasing, driven by a growing awareness of animal welfare and efforts to reduce stray populations. The State of Pet Homelessness Index by Mars Petcare (2024) estimates that 1 in 3 companion animals globally-over 600 million dogs and cats-are homeless or at risk, underscoring the urgent need for adoption programs. This has spurred global efforts, including education campaigns and partnerships, resulting in improved household adoption rates and shifting perceptions toward shelter animals. For instance, in the US, approximately 4.2 million dogs and cats were adopted from shelters in 2024, with adoption rates rising to 57% for dogs and 64% for cats. This adoption is motivated by compassion and the lower acquisition cost, with ownership trends showing an upward trajectory compared to previous decades.

The escalation in pet ownership and companion animal adoption fuels demand for veterinary diagnostic kits in India by increasing the need for timely disease detection, health monitoring, and preventive care for pets.

The veterinary diagnostics products market analysis has been carried out by considering the following segments: product, animal type, application, and end user, and geography. In terms of animal type, the veterinary diagnostics products market is bifurcated into companion animals and livestock animals. The companion animal segment held a larger market share in 2024.

Based on product, the veterinary diagnostics products market is categorized into kits, reagents, and analyzers. The kits and reagents segment accounted for the largest share of the veterinary diagnostics products market in 2024. By application, the veterinary diagnostics products market is bifurcated into infectious diseases and non-infectious diseases. The infectious diseases segment held a larger market share in 2024. Rising zoonotic disease incidence, such as canine parvovirus and avian influenza, necessitates rapid diagnostic tools like PCR and ELISA to control spread and improve treatment outcomes. According to the World Organisation for Animal Health (WOAH) 2025 report, infectious animal disease outbreaks more than doubled globally from 459 in 2023 to 1,022 in 2024 across 55 countries, including major spread of avian influenza, African swine fever, and Peste des petits ruminants (PPR). This rise in outbreaks, many with zoonotic potential, underlines an urgent need for timely and accurate diagnostic tools to contain and manage disease transmission in both livestock and companion animals.

Based on end users, the veterinary diagnostics products market is categorized into public healthcare facilities and private healthcare facilities. The public healthcare facilities segment held a larger share of the market in 2024. Public healthcare facilities play a crucial role as primary users of veterinary diagnostic products. These facilities are often responsible for monitoring and controlling zoonotic diseases-diseases that are transmitted between animals and humans-which have a direct impact on public health. Veterinary diagnostic labs within these facilities enable early disease detection, outbreak control, and surveillance, thereby supporting broader One Health initiatives. The COVID-19 pandemic highlighted the importance of integrated veterinary diagnostics in public health for identifying emerging zoonotic diseases and preventing future pandemics.

Recent investments, such as the upgrade of Sierra Leone's Central Veterinary Lab to Biosafety Level 2 with the support of FAO and USAID, demonstrate how public health facilities utilize veterinary diagnostics to protect both human and animal health simultaneously. The growing interest in veterinary diagnostics in public healthcare can be attributed to an increased awareness of the interconnectedness of animal and human health. Technological advances, such as portable and digital diagnostic platforms, facilitate rapid disease identification even in remote or resource-limited settings, making veterinary diagnostics more feasible and appealing within public healthcare. The demand for reliable and rapid diagnostic solutions has surged in recent years due to emerging disease threats and global health initiatives, as evidenced by investments in diagnostic infrastructure and technology adoption worldwide. This growing emphasis underscores the critical intersection of animal and human health through veterinary diagnostics within public health systems.

Veterinary Diagnostics Products Market Share, by End User, 2024 (%)

Source: The Insight Partners Analysis

The geographic scope of the veterinary diagnostics products market report includes assessing the market performance in North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America is expected to dominate the market in 2024. The veterinary diagnostics products market in North America is segmented into the US, Canada, and Mexico. The US veterinary diagnostics products market expansion is attributed to growing technological advancements, increasing pet ownership, and a rising focus on animal health. Innovations in diagnostic technologies, including artificial intelligence (AI), molecular diagnostics, and point-of-care platforms, fuel this expansion. Zomedica has launched the TRUFORMA system. This point-of-care diagnostic platform uses bulk acoustic wave technology for real-time diagnostics. This platform addresses a substantial market opportunity and has expanded its reach beyond the US following CE mark certification in 2024, enabling entry into the market in Europe.

Artificial intelligence is also pivotal in enhancing diagnostic accuracy and efficiency. For instance, a study developed a machine learning algorithm capable of classifying clinical wellness visits in cats and dogs with high sensitivity and specificity, facilitating early disease detection during routine check-ups. Moreover, advancements in radiology data generation using generative active learning frameworks address data scarcity issues, improving the development of computer-aided diagnostic systems in veterinary medicine.

The US market is also witnessing consolidation and strategic partnerships among key industry players. Zoetis reported high demand for pet treatments and vaccines in 2024, resulting in updated revenue forecasts. Even with staffing shortages and rising costs affecting visits to veterinary clinics, Zoetis is observing an expansion owing to its treatments for chronic pet conditions.

Additionally, the expanding diagnostic platforms in the US is expected to increase the reach and impact of veterinary diagnostics in the coming years.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com